Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy

Seungmin Lee, Heejung Kim, Ryul Kim, Bora Jin, Seoyeon Kim, Su Hyeon Ha, Jung Hwan Shin, Beomseok Jeon, Han-Joon Kim, Jee-Young Lee · 2025

Read Plasma NFL, GFAP, sTREM2, pTau231, and clinical severity in progressive supranuclear palsy by Seungmin Lee, Heejung Kim, Ryul Kim, Bora Jin, Seoyeon Kim, Su Hyeon Ha, Jung Hwan Shin, Beomseok Jeon, Han-Joon Kim, Jee-Young Lee (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12743097.txt.

Description

Seungmin Lee and colleagues measure four blood markers against severity in progressive supranuclear palsy. Their study from twenty twenty-five uses a Korean patient cohort. This movement disorder lacks simple blood measures of progression. Candidate markers cover nerve damage, inflammation, and tau protein.

Sixty-eight patients were compared with thirty healthy controls. One marker, neurofilament light chain, clearly differed between groups. Its level tracked clinical rating scale severity closely. It also tracked lower thinking test scores in patients. Marker interrelations appeared in patients but not controls. A three-marker combination separated groups best overall. Blood testing could ease monitoring of this rare disease.

Catalog record

CREATORSeungmin Lee, Heejung Kim, Ryul Kim, Bora Jin, Seoyeon Kim, Su Hyeon Ha, Jung Hwan Shin, Beomseok Jeon, Han-Joon Kim, Jee-Young Lee
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12743097

Browse the full library · About the Tower of Babel